Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic

Pulm Pharmacol Ther. 1999;12(2):131-5. doi: 10.1006/pupt.1999.0181.
No abstract available

Publication types

  • Review

MeSH terms

  • Asthma / drug therapy*
  • Cyclohexanecarboxylic Acids / therapeutic use*
  • Drug Approval
  • Humans
  • Lung Diseases, Obstructive / drug therapy
  • Nitriles
  • Phosphodiesterase Inhibitors / therapeutic use*

Substances

  • Cyclohexanecarboxylic Acids
  • Nitriles
  • Phosphodiesterase Inhibitors
  • Cilomilast